PAB 0.00% 0.7¢ patrys limited

Ann: Stable Cell Line for Production of PAT-DX3 Established, page-42

  1. 551 Posts.
    lightbulb Created with Sketch. 89
    Patrys CEO and MD, Dr James Campbell, was interviewed by Proactive’s Andrew Scott today to discuss the importance of the Company’s news that it has now developed and optimised a stable cell line for production of our full-sized IgG deoxymab, PAT-DX3.
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $14.40M
Open High Low Value Volume
0.6¢ 0.7¢ 0.6¢ $1.28K 190K

Buyers (Bids)

No. Vol. Price($)
28 5431591 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 1528945 4
View Market Depth
Last trade - 10.41am 15/07/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.